ServiziMenu principaleHome
You are here: Home > What we do > Past events > 2020 > CANCELLED: 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

CANCELLED: 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology

Not eligible for ESCO credits

14.05.2020  -  19.05.2020

Vodice, Croatia


Medical / clinical oncology

Important information

On behalf of ESO and ESMO, we would like to inform you that due to the ongoing Coronavirus (COVID-19) crisis we have made the difficult decision to cancel the 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, 14-19 May 2020, Vodice, Croatia.

We deeply regret having to take this decision but we feel that in the current climate we all need to do our part in trying to limit the diffusion of the virus as much as possible and this was the only decision possible considering your role in society as medical staff.

We have discussed the possibility of postponing the event to later this year, but due to other already planned activities we have decided that postponing is not a viable solution.

We apologize for any inconvenience caused but we think you’ll all agree that this solution was unavoidable.


Chairs: A. Eniu, CH - C. Zielinski, AT
Host chair: E. Vrdoljak, HR
ESO Masterclass Coordinator: N. Pavlidis, GR

This residential programme has been designed for medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology.
The programme focuses on cancer pathology and molecular biology, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion.
All participants will reside at the Masterclass venue and participation is mandatory throughout the course. At the end of each of the five days a learning self-assessment discussion with the chair of the course will be provided.

• To update the knowledge on basic science of clinical and medical oncology
• To enhance the competence and practical performance in systemic therapy of malignancies
• To enhance the competence and practical performance in multidisciplinary cancer care
• To update knowledge and get additional skills in supportive as well as palliative care
• To prepare for the board exam in clinical/medical oncology

• A five day residential, educational event
• Full immersion
• Clinically oriented
• Multidisciplinary

• Cancer biology/pathology
• Cancer genetics
• Pharmacology of anti-cancer drugs
• Breast cancer
• Gastro-intestinal tumours
• Gynaecological tumours
• Symptom management in gynaecological cancers
• Head and neck cancers
• Lung cancer and mesothelioma
• Genito-urinary cancers
• Palliative and supportive care
• Haematological malignancies

The Eastern Europe
and Balkan Region Masterclass in
Medical Oncology is an
ESO-ESMO joint event


In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

Download PDF document


J. Beyer, University Hospital Zürich, CH
S. Bosnjak, Institute of Oncology and Radiology of Serbia, Belgrade, RS
E. Brain, Marie Curie Institute, Paris, FR
M.J. Cardoso, Champalimaud Cancer Center, Lisbon, PT
S. Cascinu, Università di Modena e Reggio Emilia, Modena, IT
T. Cufer, University Clinic Golnik, Golnik, SI
O. Dafni, National and Kapodistrian University of Athens, Athens, GR
A. Eniu, Riviera-Chablais Vaud-Valais, Rennaz, CH
F.B. Geara, American University of Beirut Medical Center, Beirut, LB
M. Halaska, Charles University, Prague, CZ
M.A. Hoda, Medical University Vienna, Vienna, AT
D. Jovanovic, Clinical Center of Serbia, Belgrade, RS
I. Kern, University Clinic Golnik, Golnik, SI
S. Martin Algarra, University Clinic of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, ES
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, CH
M. Porebiak, SWPS University of Social Sciences and Humanities, Warsaw, PL
C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
C. Sotiriou, Institut Jules Bordet, Brussels, BE
S. Tomic, Clinical Institute of Pathology KBC Split, Split, HR
J.B. Vermorken, Antwerp University Hospital, Edegem, BE
E. Vrdoljak, Clinical Hospital Split, Medical School Split, Split, HR
C. Zielinski, Comprehensive Cancer Center Vienna, Vienna, AT
E. Zucca, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH

General information

Dolores Knupfer
European School of Oncology - Bellinzona Office
Piazza Indipendenza 2
CH 6500 Bellinzona - Switzerland
Tel: +41 91 820 0952
Fax: +41 91 820 0953
Email: dknupfer@eso.net

The Masterclass will be held in English and translation will not be provided.

The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

The 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The programme has been granted up to 26 European CME credits (ECMEC) . Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
The programme has also been submitted to ESMO for ESMO-MORA accreditation.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.


• Age between 30 and 40 years
• 2-3 years’ experience in oncology
• Involvement in scientific activities and clinical trials
• Fluency in English

Admittance to the Masterclass is by competitive application. The successful applicants are granted free registration, full board, airport transfer to the course venue and accommodation in Vodice for the period 14-19 May 2020. Travel will be covered by the participants.
All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course.
The Masterclass will be taught entirely in English and fluency in English is necessary for admission.

Priority will be given to candidates practicing in Eastern Europe and Balkan region countries.

Successful applicants are granted free registration and accommodation


14 May

18:00   Registration
18:30   Welcome address and general introduction
A. Eniu, CH - N. Pavlidis - GR, E. Vrdoljak, HR
18:45   Access to care: an old/new issue? Global and Eastern European issues
A. Eniu, CH
19:05   Discussion
19:15   Access to diagnoses and drugs in NSCLC in central and southeastern Europe
T. Cufer, SI
19:35   Discussion
20:00   Dinner    


 15 May

Chairs: J. Beyer, CH - F.B. Geara, LB  
 9:00   Local therapy for prostate cancer
(surgery and radiotherapy)

F.B. Geara, LB
 9:20   Discussion
 9:30   Metastatic prostate cancer
J. Beyer, CH
 9:50   Discussion
 10:00   Testicular cancer
J. Beyer, CH
 10:20   Discussion   
 10:30   Systemic treatment of advanced renal cancer
J. Beyer, CH
 10:50   Discussion
 11:00   Coffee break
11:30   Tumor board on genito-urinary tumours
 12:15   Lunch
 13:30   How to prepare and deliver a successful public presentation
J. Beyer, CH
 13:50   Discussion
 14:00   Statistics in oncology, critical reading clinical trials design and publications…
O. Dafni, GR
 14:25   Discussion
14:30   Coffee break
15:00   IPOS lecture: Communication skills as first level psycho-social care
M. Porebiak, PL
15:30   Discussion
(3 groups in parallel, 15 cases)
T. Cufer, SI - A. Eniu, CH - R. Popescu, CH - N. Pavlidis, GR
 20:00   Dinner


 16 May

8:30   Advances in the management of non-Hodgkin's lymphoma
E. Zucca, CH
8:50   Discussion
9:00   Management of cancer in the elderly
E. Brain, FR
9:20   Discussion
Chairs: T. Cufer, SI - E. Vrdoljak, HR  
9:30   Breast cancer pathology and molecular biology
S.Tomic, HR
9:50   Discussion         
10:00   Optimal surgical management of breast cancer
M.J. Cardoso, PT
10:20   Discussion  
10:30   Coffee break
11:00   The role of radiotherapy in early and advanced BC
E. Vrdoljak, HR
11:20   Discussion
11:30   Optimal approach in locally advanced disease: ESO-ESMO ABC Guidelines
A. Eniu, CH
11:50   Discussion   
 12:00   Systemic treatment of luminal early and advanced breast cancer
A. Eniu, CH
 12:20   Discussion   
 12:30   Systemic treatment of HER2-positive early and advanced BC
T. Cufer, SI      
13:00   Lunch
  Systemic treatment of TN early and advanced BC
C. Sotiriou, BE
 14:50   Discussion
15:00   Cancer genomics for the practising oncologist
C. Sotiriou, BE
15:20   Discussion
 13:30   Coffee break
16:00   Tumor board on breast cancer
 19:00   Dinner


 17 May

Chairs: S. Cascinu, IT - D. Papamichael, CY
8:30   Adjuvant/neoadjuvant systemic treatment of colorectal cancer
D. Papamichael, CY
8:50   Discussion
9:00   Systemic treatment of advanced colorectal cancer
D. Papamichael, CY
9:20   Discussion
9:30   Coffee break
10:00   Optimal management of metastatic gastric cancer in 2020  
S. Cascinu, IT
10:20   Discussion
10:30   Adjuvant/neo-adjuvant therapy in GEJ/Stomach adenocarcinoma 
S. Cascinu, IT
10:50   Discussion
11:00   Tumour board on gastro-intestinal tumours
S. Cascinu, IT - D. Papamichael, CY
11:45   Lunch
Chair: C. Sessa, CH
13:00   Screening of cervical cancer
C. Sessa, CH
13:30   Discussion
13:40   Role of surgery in gynaecological cancer
M. Halaska, CZ
14:10   Discussion
14:20   Systemic management of ovarian cancer
J.B. Vermorken, BE
14:50   Discussion
15:00   Systemic management of cervical and endometrial
C. Sessa, CH
15:50   Discussion
16:00   Coffee break
16:15   Tumor board on gynaecological tumours 
17:00   Therapeutic management of head and neck cancers
J.B. Vermorken, BE
17:30   Discussion
17:40   Tumour board on head and neck cancers
J.B. Vermorken, BE
20:00   Dinner


18 May

Chairs: T. Cufer, SI, D. Jovanovic, RS
9:00   Lung cancer pathology and molecular biology
I. Kern, SI
9:20   Discussion
9:30   Surgery for lung cancer and malignant pleural mesothelioma M.A. Hoda, AT
9:50   Discussion
10:00   Optimal management of stage III disease D. Jovanovic, RS
10:30   Coffee break
11:00   Targeted agents in NSCLC cancer
T. Cufer, SI
11:20   Discussion
11:30   Standard of care of SCLC and future directions
D. Jovanovic, RS
11:50   Discussion
12:00   Systemic management of mesothelioma
D. Jovanovic, RS
12:20   Discussion
12:30   The diagnostic and therapeutic management of Cancer of Unknown Primary
N. Pavlidis, GR
12:50   Discussion
13:00   Lunch
14:30   Tumor board on lung cancer
15:15   Systemic management of pancreatic cancer
R. Popescu, CH
15:35   Discussion
15:45   Benefits of early integration of cancer care and palliative care
S. Bosnjak, RS
16:05   Discussion
16:15   Supportive care
S. Bosnjak, RS
16:35   Discussion
16:45   Coffee break
(3 groups in parallel, 15 cases)
N. Pavlidis, GR - R. Popescu, CH - C. Zielinski, AT


 19 May

9:00   Management of melanoma with immunotherapy and targeted treatment
S. Martin-Algarra, ES
9:20   Discussion
9:30   Learning self-assessment test
10:20   Immune check point inhibitors: Immunologic background, indications and innovations
C. Zielinski, AT
10:50   Discussion
 11:00   Close
 11:30   Standing lunch and departures